Home
About
Overview
Sharing Data
ORCID
Help
History (91)
An expert panel consensus on opioid-prescribing guidelines for dermatologic procedures.
Hiser, William
Impella assisted transradial coronary intervention in patients with acute coronary syndromes and cardiogenic shock: case series.
Histological Composition and the Origin of the Thrombus: A New Diagnostic Assay for Secondary Stroke Prevention?
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases.
See All 91 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases.
Kay J, Cross RK, Feldman SR, Park Y, Hanauer SB. Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases. Adv Ther. 2024 02; 41(2):509-533.
View in:
PubMed
subject areas
Adalimumab
Arthritis, Rheumatoid
Biosimilar Pharmaceuticals
Crohn Disease
Humans
Treatment Outcome
Tumor Necrosis Factor-alpha
authors with profiles
Jonathan Kay MD